176 related articles for article (PubMed ID: 20032465)
1. Down-regulation of S1P1 receptor surface expression by protein kinase C inhibition.
Sensken SC; Gräler MH
J Biol Chem; 2010 Feb; 285(9):6298-307. PubMed ID: 20032465
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of protein kinase C involved in phorbol ester-induced sphingosine 1-phosphate receptor 1 phosphorylation and desensitization.
Morquecho-León MA; Bazúa-Valenti S; Romero-Ávila MT; García-Sáinz JA
Biochim Biophys Acta; 2014 Feb; 1843(2):327-34. PubMed ID: 24239722
[TBL] [Abstract][Full Text] [Related]
3. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
[TBL] [Abstract][Full Text] [Related]
5. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.
Koch A; Völzke A; Puff B; Blankenbach K; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
Biochim Biophys Acta; 2013 Nov; 1831(11):1634-43. PubMed ID: 23906789
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Sensken SC; Bode C; Gräler MH
J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
8. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.
Tarrasón G; Aulí M; Mustafa S; Dolgachev V; Domènech MT; Prats N; Domínguez M; López R; Aguilar N; Calbet M; Pont M; Milligan G; Kunkel SL; Godessart N
Int Immunopharmacol; 2011 Nov; 11(11):1773-9. PubMed ID: 21798372
[TBL] [Abstract][Full Text] [Related]
9. Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells.
Xin C; Ren S; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2004 Nov; 143(5):581-9. PubMed ID: 15466446
[TBL] [Abstract][Full Text] [Related]
10. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
11. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
Sensken SC; Nagarajan M; Bode C; Gräler MH
J Immunol; 2011 Mar; 186(6):3432-40. PubMed ID: 21289303
[TBL] [Abstract][Full Text] [Related]
12. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
Gräler MH; Goetzl EJ
FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
[TBL] [Abstract][Full Text] [Related]
14. S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.
Maeda Y; Yagi H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Masuko T; Chiba K
Int Immunol; 2014 May; 26(5):245-55. PubMed ID: 24343820
[TBL] [Abstract][Full Text] [Related]
15. Finding a way out: lymphocyte egress from lymphoid organs.
Schwab SR; Cyster JG
Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells.
Nodai A; Machida T; Izumi S; Hamaya Y; Kohno T; Igarashi Y; Iizuka K; Minami M; Hirafuji M
Life Sci; 2007 Apr; 80(19):1768-76. PubMed ID: 17382352
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics.
Thangada S; Khanna KM; Blaho VA; Oo ML; Im DS; Guo C; Lefrancois L; Hla T
J Exp Med; 2010 Jul; 207(7):1475-83. PubMed ID: 20584883
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
20. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
